Universal Ibogaine Inc. (IBOGF)
OTCMKTS · Delayed Price · Currency is USD
0.0063
+0.0003 (4.50%)
Nov 5, 2025, 11:54 AM EST
Universal Ibogaine Revenue
Universal Ibogaine had revenue of 700.92K CAD in the quarter ending April 30, 2025, with 30.61% growth. This brings the company's revenue in the last twelve months to 2.06M, down -11.68% year-over-year. In the fiscal year ending July 31, 2024, Universal Ibogaine had annual revenue of 2.33M with 126.32% growth.
Revenue (ttm)
2.06M CAD
Revenue Growth
-11.68%
P/S Ratio
0.75
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.11M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jul 31, 2024 | 2.33M | 1.30M | 126.32% |
| Jul 31, 2023 | 1.03M | -40.82K | -3.81% |
| Jul 31, 2022 | 1.07M | - | - |
| Jul 31, 2021 | - | - | - |
| Jul 31, 2020 | - | - | - |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 260.43M |
| Glass House Brands | 221.55M |
| Global Cord Blood | 196.10M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 2.61M |
Universal Ibogaine News
- 8 days ago - Universal Ibogaine Provides Corporate Update - TheNewswire
- 6 weeks ago - Universal Ibogaine Announces Board Changes - TheNewswire
- 7 weeks ago - Universal Ibogaine Announces Results of the Annual Meeting of Shareholders - TheNewswire
- 2 months ago - Universal Ibogaine Inc. provides update on intent to file Clinical Trial Application with Health Canada and confirms securing of Ibogaine drug supply - TheNewswire
- 2 months ago - Universal Ibogaine advises of appointment of two new Board Members - TheNewswire
- 3 months ago - Universal Ibogaine advises of departure of CFO - TheNewswire
- 4 months ago - Universal Ibogaine Advises of Debt Settlement with CEO and Resignation of a Member of its Board of Directors - TheNewswire
- 7 months ago - Universal Ibogaine Advises of Debt Settlement Agreement and Update on Status of Cease Trade Order - TheNewswire